Abstract
Botulinum toxin drugs have an excellent safety profile. Adverse events are most often related to the local diffusion of the toxin and are usually mild and transient. However, there are cases where the clinical manifestations following the injection cannot so easily be explained. We describe a case of myasthenia gravis following periocular botulinum injection.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
